Precision Medicine

The historical classification of the PVT1 locus as a non-coding region has been overturned by evidence showing it produces functional proteins that dictate the survival of malignant cells. For decades, the oncology community has viewed the MYC gene as the most frustrating obstacle in cancer

For centuries, the sight of multiple individuals resting in a single medieval grave was interpreted by archaeologists as a poignant snapshot of a family unit, perhaps a mother and child or siblings, bound together even in death. This romanticized view suggested that the biological nuclear family

A major challenge in pharmaceutical development is the high failure rate of programs that stall because a target protein’s structure cannot be mapped. For many years, the pharmaceutical industry relied heavily on physical laboratory experiments that were both time-consuming and prone to human

CRISPRLungo focuses on classifying the complete diversity of editing outcomes instead of reducing results to a single percentage of efficiency. As gene-editing technology transitions from a research laboratory curiosity to a cornerstone of clinical medicine and industrial agriculture, the demand

The pharmaceutical industry is currently witnessing a seismic transition that rivals the historical shift from basic alchemy to modern chemistry, as digital precision begins to replace the traditional reliance on serendipitous discovery. Closed-loop systems where AI predictions are immediately

By repurposing the DNA samples already collected for monogenic testing, healthcare systems can implement polygenic risk scoring without adding significant costs or delays to the diagnostic process. This technological leap addresses the grueling reality of thousands of young patients who have faced